Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

Meta-Analysis of Oxidative Stress in Schizophrenia

(2013) Joshua Flatow et al.   BIOLOGICAL PSYCHIATRY

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

(2013) S Smesny et al.   MOLECULAR PSYCHIATRY

Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for Psychosis

(2013) Barnaby Nelson et al.   JAMA Psychiatry

Predicting Psychosis

(2012) Paolo Fusar-Poli   ARCHIVES OF GENERAL PSYCHIATRY

Eicosapentaenoic Acid Interventions in Schizophrenia

(2012) Paolo Fusar-Poli et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review

(2012) Graziella Orrù et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression

(2012) George Anderson et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis

(2012) Wendela P. Hoen et al.   PSYCHIATRY RESEARCH

At Clinical High Risk for Psychosis: Outcome for Nonconverters

(2011) Jean Addington et al.   AMERICAN JOURNAL OF PSYCHIATRY

Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk

(2011) Artemis P Simopoulos   EXPERIMENTAL BIOLOGY AND MEDICINE

Omega-3 Fatty Acids and Cardiovascular Disease

(2011) Dariush Mozaffarian et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

(2011) G P Amminger et al.   MOLECULAR PSYCHIATRY

Update on Omega-3 Polyunsaturated Fatty Acids in Early-Stage Psychotic Disorders

(2011) G Paul Amminger et al.   NEUROPSYCHOPHARMACOLOGY

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders

(2010) G. Paul Amminger et al.   ARCHIVES OF GENERAL PSYCHIATRY

Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder

(2010) Barbara L Gracious et al.   BIPOLAR DISORDERS

Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population

(2010) Maria Hedelin et al.   BMC Psychiatry

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

(2010) M. Berk et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia

(2010) M.M. Sethom et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Niacin sensitivity and the arachidonic acid pathway in schizophrenia

(2010) Erik Messamore et al.   SCHIZOPHRENIA RESEARCH

Quantitative prediction of subjective pain intensity from whole-brain fMRI data using Gaussian processes

(2009) Andre Marquand et al.   NEUROIMAGE

α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans

(2009) J. Thomas Brenna et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Prediction of Psychosis in Youth at High Clinical Risk

(2008) Tyrone D. Cannon et al.   ARCHIVES OF GENERAL PSYCHIATRY

Brain foods: the effects of nutrients on brain function

(2008) Fernando Gómez-Pinilla   NATURE REVIEWS NEUROSCIENCE

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study

(2008) Gregor E Berger et al.   NEUROPSYCHOPHARMACOLOGY